Toxicity of concurrent vs Sequential ChemoRadiotherapy
Most prospective studies show an increase in the toxicity in the elderly treated with concurrent treatment
•RTOG 94-10: patients ≥70 were more likely to experience oesophagitis (33% ≥G2 vs 23%)
•Others have shown higher rates of pulmonary toxicity for those ≥70.
•However one subgroup showed similar rates of oesophagitis and pneumonitis • Subgroup of the Lung Adjuvant Cisplatin Evaluation study found that age did not affect outcome but those >70 had lower chemotherapy doses and less cycles.
